Tag results:
Industry & Policy News
Intestinal Cell News
Researchers Receive Grant to Boost Colorectal Cancer Screening Follow-Up in Underserved Communities
[UCLA Health] Researchers from the University of California, Los Angeles (UCLA) Health Jonsson Comprehensive Cancer Center were awarded a $3 million grant from the National Institutes of Health to improve follow-up care for colorectal cancer screening in underserved populations.
Intestinal Cell News
Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase IIb Trial of Obefazimod in Crohn’s Disease
[Abivax] Abivax SA announced the first patient was enrolled in its Phase IIb ENHANCE-CD trial evaluating obefazimod in patients with Crohn’s disease.
Cell Therapy News
World-First Therapy Using Donor Cells Sends Autoimmune Diseases into Remission
[Nature News] One woman and two men with severe autoimmune conditions have gone into remission after being treated with bioengineered and CRISPR-modified immune cells1. The three individuals from China are the first people with autoimmune disorders to be treated with engineered immune cells created from donor cells, rather than ones collected from their own bodies.
Newsletters
Curium Announces Strategic Partnership with PeptiDream for Prostate Cancer Theranostics in Japan
[Curium] Curium announced that it has entered into a strategic partnership with PDRadiopharma, Inc, a wholly-owned subsidiary of PeptiDream, for the clinical development, regulatory filing, and commercialization in Japan of 177Lu-PSMA-I&T and 64Cu-PSMA-I&T.
Newsletters
UK Black Men Are 2.5 Times As Likely To Die From Prostate Cancer
[Forbes] A “dangerously biased” combination of social factors and inadequate research is raising Black men’s already-heightened risk of developing prostate cancer, a UK charity has stated
Human Immunology News
Dartmouth Researchers Receive Funding Awards to Develop New Vaccines
[Dartmouth Geisel School of Medicine] Drs. David Leib and Margaret Ackerman will be among the recipients of grant funding from the Biden-Harris Administration’s Advanced Research Program for Health to support innovations in pandemic preparedness and vaccine generation.